← All diseases Brain and nervous system

Multiple sclerosis (progressive)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of the highest level only (104)Meta-analysis (24)Treatment guideline (1)Randomized trial (43)Systematic review (21)Phase 3 Study (15)Clinical trial (370)Review article (234)Early study (phase 1 or 2) (22)Case report (83)Laboratory or animal study (21)Commentary or editorial (19) Studies currently recruiting participants only (33)

Filter

Publications and studies (1542)

• Commentary or editorialiAn expert's opinion or commentary, not new research. N,N-Dimethylglycine in patients with progressive multiple sclerosis: result of a pilot double-blind, placebo, controlled randomized clinical trial. (2021/05/24) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neurology of inflammatory bowel disease. (2021/05/15) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Overground Robotic Program Preserves Gait in Individuals With Multiple Sclerosis and Moderate to Severe Impairments: A Randomized Controlled Trial. (2021/05/01) ♡
• Results of three or more Gamma Knife radiosurgery procedures for recurrent trigeminal neuralgia. (2021/04/23) ♡
• The Impact of Epigallocatechin Gallate and Coconut Oil Treatment on Cortisol Activity and Depression in Multiple Sclerosis Patients. (2021/04/17) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders. (2021/04/08) ♡
• Cuprizone-induced demyelination triggers a CD8-pronounced T cell recruitment. (2021/04/01) ♡
• Decreasing brain iron in multiple sclerosis: The difference between concentration and content in iron MRI. (2021/04/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. New insights into the socio-economic aspects of multiple sclerosis in a cohort of Polish patients. (2021/03/18) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Natalizumab: safety and risk in patients with relapsing-remitting multiple sclerosis. (2021/03/01) ♡
• Vitamin D Levels and Visual System Measurements in Progressive Multiple Sclerosis: A Cross-sectional Study. (2021/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acupuncture in Post-Stroke Shoulder Pain Syndrome with Multiple Sclerosis: A Case Study. (2021/02/28) ♡
• Diagnosis of multiple sclerosis in times of MOG and AQP4 autoantibody testing - A monocentric study. (2021/02/15) ♡
• Effect of Etazolate upon Cuprizone-induced Demyelination In Vivo: Behavioral and Myelin Gene Analysis. (2021/02/10) ♡
• Living with secondary progressive multiple sclerosis in Europe: perspectives of multiple stakeholders. (2021/02/01) ♡
• Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis. (2021/02/01) ♡
• Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high-dose pharmaceutical-grade biotin (MD1003). (2021/02/01) ♡
• Risk factors for infusion-related reactions following Ocrelizumab infusion in a community setting: Development of an electronic medical record-based explanatory model. (2021/02/01) ♡
• Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). (2021/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Real-world experience of ocrelizumab in multiple sclerosis in a Spanish population. (2021/02/01) ♡
• Physiotherapy use and access-barriers in persons with multiple sclerosis: A cross-sectional analysis. (2021/02/01) ♡
• Influence of delaying ocrelizumab dosing in multiple sclerosis due to COVID-19 pandemics on clinical and laboratory effectiveness. (2021/02/01) ♡
• How may patients with MS benefit from using music assisted therapy? A case-control feasability study investigating motor outcomes and beyond. (2021/02/01) ♡
• Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage. (2021/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent developments on PET radiotracers for TSPO and their applications in neuroimaging. (2021/02/01) ♡
• Lateral Suboccipital Approach in Semisitting Position for Resection of Vagal Schwannoma: 2-Dimensional Operative Video. (2021/02/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Ibudilast: A Paradigm Shift for Progressive Multiple Sclerosis? (2021/01/26) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study. (2021/01/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis. (2021/01/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Should We Use Clinical Tools to Identify Disease Progression? (2021/01/21) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Siponimod for Cognition in Secondary Progressive Multiple Sclerosis: Thinking Through the Evidence. (2021/01/19) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Siponimod and Cognition in Secondary Progressive Multiple Sclerosis: EXPAND Secondary Analyses. (2021/01/19) ♡
• Ocrelizumab in Multiple Sclerosis: A Real-World Study From Spain. (2021/01/15) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Efficacy of High-Intensity Aerobic Exercise on Brain MRI Measures in Multiple Sclerosis. (2021/01/12) ♡
• Duration-dependent extensive volume and shape changes of mesolimbic structures in surgically treated unilateral patients with temporal lobe epilepsy. (2021/01/01) ♡
• FXTAS presents with upregulation of the cytokines IL12 and TNFα. (2021/01/01) ♡
• Variations in consecutive serum neurofilament light levels in healthy controls and multiple sclerosis patients. (2021/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Preventive neurology concepts for training the next-generation and closing gaps in real-world Multiple Sclerosis Care. (2021/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MRI signs of CNS demyelinating diseases. (2021/01/01) ♡
• Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis. (2021/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Critically appraised paper: A home-based standing frame program may improve motor function in people with progressive multiple sclerosis [commentary]. (2021/01/01) ♡
• Revealing vascular abnormalities and measuring small vessel density in multiple sclerosis lesions using USPIO. (2021/01/01) ♡
• Deregulation of phosphatidylinositol-4-phosphate in the development of amyotrophic lateral sclerosis 8. (2021/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe Delayed-Onset Neutropenia Induced by Ocrelizumab. (2021/01/01) ♡
• Clinical characteristics of a large multi-center cohort of people with multiple sclerosis over age 60. (2021/01/01) ♡
• COGNITIVE FUNCTIONS IN MULTIPLE SCLEROSIS PATIENTS DEPENDING ON THE DIFFERENT RISK FACTORS PRESENCE. (2021/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients (2021-10-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis (2021-09-21) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Neural Stem Cell Transplantation in Multiple Sclerosis Patients (2021-09-05) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sensitivity of Motor Assessment in MS - a Prospective Cohort Study (2021-08-10) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.